Vision 2030: Advancing Clinical Research with Patient-Generated Health Data

DiMe and FDA are jointly leading a public meeting to identify the best practices for using Patient-Generated Health Data (“PGHD”) and improve the attendees’ understanding of PGHD implementation during medical device development and clinical studies. Using insights from this meeting, they will develop resources to help key stakeholders implement PGHD throughout the total product life cycle.